Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-25
2006-04-25
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S471000, C549S071000, C549S072000, C549S073000, C549S484000, C549S486000
Reexamination Certificate
active
07034053
ABSTRACT:
The present invention disclosed compounds of Formula I. The present invention also discloses beta-3 agonists of formula I and methods for treating beta-3 mediated diseases and condition using the compounds of formula I, in particular methods for treating diabetes or obesity.
REFERENCES:
patent: 0 455 006 (1991-06-01), None
patent: 0 565 317 (1993-10-01), None
patent: 95/33724 (1995-12-01), None
patent: 97/21665 (1997-06-01), None
patent: 99/65877 (1999-12-01), None
Lezama, Edwin J., et al., “Pharmacological Study of Atypical-Adrenoceptors in Rat Esophageal Smooth Muscle,” European Journal of Pharmacology, vol. 308, May 16, 1996, p0p. 69-80.
Deaton David N.
Shearer Barry George
Uehling David Edward
Fix Amy H.
Sackey Ebenzer
SmithKline Beecham Corporation
Solola Taofiq
LandOfFree
Phenethanolamine derivatives, compositions, and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenethanolamine derivatives, compositions, and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenethanolamine derivatives, compositions, and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3600422